Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
Date:7/25/2008

ctured product margins have remained fairly stable, yet are slightly higher, primarily due to product sales mix. We are hopeful that these margins continue as we manage, among other things, various factors such as changes in product sales mix, the balance of product sold to the various classes of trade, new product launches and continued price erosion. We cannot determine the weight of distributed product sales versus manufactured product sales in any given period, as it depends on our ability to gain market share on each product, and is relative to when the FDA approves any given product in either category of product and the revenue potential of that product once it has been approved."

Selling, general and administrative ("SG&A") expenses during the first quarter of Fiscal 2009 were $3.8 million, as compared to $3.4 million during the corresponding period of Fiscal 2008, representing an increase of 12%. The increase was mainly related to higher marketing and administrative efforts relative to the increase in sales. SG&A expenses, as a percentage of net sales, improved to 4% for the first quarter of Fiscal 2009, as compared to 10% for the corresponding period of Fiscal 2008. The lower SG&A, as a percentage of sales, is primarily due to increased sales of distributed products.

Total R&D expenses for the first quarter of Fiscal 2009 were $5.5 million, as compared to $3.3 million during the corresponding period of Fiscal 2008. The Company did not incur any non-cash R&D expenses (technology transfer costs) during the first quarter of Fiscal 2009 or during the corresponding period of Fiscal 2008, as the final product was transferred to Caraco by Sun Global during the third quarter of Fiscal 2008, which concluded the obligations between the parties under a technology transfer agreement between Caraco and Sun Global. Cash R&D will continue to increase in an effort to develop and file additional products. The cash R&D expenses during the first quarter of Fisca
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
3. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
4. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
5. Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Companys North American Headquarters
6. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
7. Anadys Pharmaceuticals to Report Second Quarter 2008 Financial Results
8. Sonus Pharmaceuticals Receives Favorable NASDAQ Decision
9. Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
10. Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering
11. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... 27, 2015 , ... The Kansas City Animal Health Investment ... health companies to hear from animal health companies with the newest technology. Companies ... agreements or distribution contracts. This meeting is one of the only investment ...
(Date:8/27/2015)... , Aug. 27, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, today announced that executives from ... the month of September.  , ... Rodman & Renshaw,s 17th Annual Global Investment Conference on ... the St. Regis Hotel in New York ...
(Date:8/27/2015)... ... August 27, 2015 , ... METTLER TOLEDO's ... narrows down the product choices to a manageable shortlist of bench and floor ... to models that fit best with the customer’s industry and application. , ...
(Date:8/26/2015)... 26, 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... testing solutions for the detection of foodborne pathogens, today ... the Sidoti & Company Emerging Growth Conference on September ... at the New York Marriott Marquis. ... through the investor relations section of Roka Bioscience,s website ...
Breaking Biology Technology:VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2METTLER TOLEDO Updates Online Scale Selection Tool 2
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) announced today that ... Rodman & Renshaw Annual Global Investment Conference taking place in London ... , , ... 5:15 a.m. Eastern Daylight Time ) on Tuesday, May 18 at ...
... PRINCETON, N.J. , May 12 ... or the Company), a late-stage biopharmaceutical company, announced ... a randomized, double-blind, placebo-controlled Phase 2 clinical trial ... disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) ...
... Fisheries Science Center placed 61 satellite tags on fur seals, ... will allow researchers and the public to track the movements ... during our summer. "We typically observe these animals during ... go during the winter when weather conditions and ice make ...
Cached Biology Technology:Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 2Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 3Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 4Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 5
(Date:8/20/2015)... Aug. 20, 2015   Sensory, Inc ., ... the user experience and security of consumer electronics ... announced that its TrulySecure™ is the ... to be FIDO Certified™. The FIDO ... with the FIDO UAF (Universal Authentication Framework) 1.0 ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas today ... contributor to the Submission Content Management webinar ... a non-profit forum. Dedicated to the Implementation of ... neutral platform for industry, vendors, health authorities, ... and work towards a standard method of ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2
... China and San Diego, CA BGI, the world,s ... privately held biotechnology company that utilizes a proven metabolic ... design of new products and processes for the life ... the genomic sequence of the Chinese hamster ovary (CHO) ...
... kill a plant may actually make it stronger. After ... plants grow bigger and faster and reproduce more successfully ... report that one secret to these plants, post-traumatic triumph ... again and again without undergoing cell division. ...
... Research Park, working with colleagues in China, have developed ... to breeding the improved varieties of crop needed to ... complicated genome of oilseed rape they have been able ... for predictive breeding. , Traditional breeding involves crossing ...
Cached Biology News:Genome of CHO-K1 provides new insights into optimization of biopharmaceutical protein production 2Genome of CHO-K1 provides new insights into optimization of biopharmaceutical protein production 3Some plants duplicate their DNA to overcome adversity 2Dissecting the genomes of crop plants to improve breeding potential 2
... NanoMate 100 robotic system and disposable ESI ... of the capabilities of electrospray mass spectrometers ... with MS allows users to either speed ... and peptide mapping applications, or long acquisition ...
... RTS AviTag E. coli Biotinylation Kit, Linear Template ... E. coli expression kits. (Cat. No. 3 186 ... to rapidly generate linear expression constructs by PCR ... on a combination of T7 RNA polymerase and ...
... enables sensitive and specific detection of microRNAs ... in situ detection probes have high binding ... sensitive detection of miRNAs. Specific in situ ... mounts, thin sections, single cells and in ...
... the major proteolytic system in the ... catalyzes the selective degradation of short-lived ... of proteins with abnormal conformation (Hershko ... critical protease in this pathway is ...
Biology Products: